Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2021 / May / Business in Brief
Business and Entrepreneurship Professional Development

Business in Brief

Find out this month’s industry happenings

By Aleksandra Jones 5/13/2021 1 min read

Share

  • Claire M. Gelfman has been appointed as the new Chief Scientific Officer of Foundation Fighting Blindness. She will be overlooking the organization’s scientific strategy with a focus on research initiatives to accelerate new therapies for inherited retinal diseases, as well as early translational and preclinical research programs. 
     
  • Quantel Medical has launched a new website to share information on dry eye disease (DED). mydryeyedisease.com will give patients a better understanding of the disease, symptoms, and causes, and help them choose the best treatments. With monthly updates and seasonal topics, the website aims to be a practical tool for ophthalmologists to share with their DED patients.
     
  • Santen has announced a global cooperation with Massachusetts Eye and Ear in Boston and Ulster University in Northern Ireland, with the aim of researching, identifying, and developing new glaucoma treatments. Research will focus on preventing and reversing optic nerve damage by exploring innovative therapeutic options for the visual nervous system.
     
  • Oertli has introduced the latest generation of its OS 4 surgical platform for cataract, glaucoma, and retinal surgery. The new platform, with a fully automated user protection filter and a three-pump fluidics system, boasts more speed, precision, and safety. Visualization is improved with the use of two Power LED light sources, which provide 45 percent more light output.
     
  • OPHTEC has introduced its new lens: the Precizon Toric and Precizon Presbyopic IOL. The IOL features a Transitional Conic Toric optic, designed for misalignment tolerance, and a Continuous Transitional Focus, providing a smooth near-to-far transition and a constant defocus between two sharp focal points, as well as a low rate of photic phenomena.

About the Author(s)

Aleksandra Jones

Having edited several technical publications over the last decade, I crossed paths with quite a few of Texere's current team members, and I only ever heard them sing the company's praises. When an opportunity arose to join Texere, I jumped at the chance! With a background in literature, I love the company's ethos of producing genuinely engaging content, and the fact that it is so well received by our readers makes it even more rewarding.

More Articles by Aleksandra Jones

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: